MX2007002531A - Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos. - Google Patents
Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.Info
- Publication number
- MX2007002531A MX2007002531A MX2007002531A MX2007002531A MX2007002531A MX 2007002531 A MX2007002531 A MX 2007002531A MX 2007002531 A MX2007002531 A MX 2007002531A MX 2007002531 A MX2007002531 A MX 2007002531A MX 2007002531 A MX2007002531 A MX 2007002531A
- Authority
- MX
- Mexico
- Prior art keywords
- norcholestane
- seco
- linear
- branched alkyl
- novel derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/385—Saturated compounds containing a keto group being part of a ring
- C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
- C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
- C07C49/513—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invencion se refiere a compuestos de la formula (I): donde X + Y = ceto, o X = OH e Y = H, o X + Y = oxima o metiloxima, B = OH y C + C = H, C + D = alquilo lineal o ramificado de 1 a 4 atomos de carbono, o C = H y D = alquilo lineal o ramificado de 1 a 4 atomos de carbono, o B + C = ceto y D = metilo, hidroxilo o metilamino , o B y C = H y D = metilamino, o B + C = oxima y D = metilo y R = alquilo lineal o ramificado de 1 a 10 atomos de carbono, las sales, los esteres, o sales de esteres de las mismas como medicamento, en particular como neuroprotectores, compuestos novedosos de la formula (I) y composiciones farmaceuticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0409436A FR2874923B1 (fr) | 2004-09-07 | 2004-09-07 | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
PCT/FR2005/002116 WO2006027454A1 (fr) | 2004-09-07 | 2005-08-19 | Nouveaux derives du 3,5-seco-4-nor-cholestane et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007002531A true MX2007002531A (es) | 2007-05-23 |
Family
ID=34949389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007002531A MX2007002531A (es) | 2004-09-07 | 2005-08-19 | Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos. |
Country Status (16)
Country | Link |
---|---|
US (1) | US9045393B2 (es) |
EP (1) | EP1786759B1 (es) |
JP (1) | JP5350630B2 (es) |
KR (1) | KR101190464B1 (es) |
CN (1) | CN101018762B (es) |
AU (1) | AU2005281640B2 (es) |
BR (1) | BRPI0514792A (es) |
CA (1) | CA2576393C (es) |
DK (1) | DK1786759T3 (es) |
ES (1) | ES2390462T3 (es) |
FR (1) | FR2874923B1 (es) |
IL (1) | IL181216A (es) |
MX (1) | MX2007002531A (es) |
PL (1) | PL1786759T3 (es) |
RU (1) | RU2398764C2 (es) |
WO (1) | WO2006027454A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2874923B1 (fr) | 2004-09-07 | 2006-10-27 | Trophos Sa | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
FR2898272B1 (fr) * | 2006-03-09 | 2008-07-04 | Trophos Sa | Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur |
FR2919182B1 (fr) * | 2007-07-25 | 2009-11-13 | Trophos | Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants |
FR2919180B1 (fr) * | 2007-07-25 | 2009-11-27 | Trophos | Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants |
FR2940650B1 (fr) * | 2008-12-29 | 2017-01-27 | Trophos | Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation |
WO2012069150A2 (en) | 2010-11-22 | 2012-05-31 | Powerpore Gmbh | Cytoprotectant agents for the prevention of drug-associated side-effects |
FR2979239A1 (fr) | 2011-08-25 | 2013-03-01 | Trophos | Liposome comprenant au moins un derive de cholesterol |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2883424A (en) * | 1956-06-20 | 1959-04-21 | Monsanto Chemicals | Dihydroxy steroid derivatives and method of preparing same |
US5646188A (en) * | 1995-07-05 | 1997-07-08 | Teva Pharmaceutical Industries, Ltd. | Polyamine derivatives of 1-aminoindan |
GB0117326D0 (en) * | 2001-07-16 | 2001-09-05 | Univ Aberdeen | Napthoquinone-type inhibitors of protein aggregation |
BRPI0408240A (pt) | 2003-03-11 | 2006-03-01 | Trophos | composto, utilização de um composto e composição farmacêutica |
FR2874923B1 (fr) | 2004-09-07 | 2006-10-27 | Trophos Sa | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
FR2894968B1 (fr) | 2005-12-20 | 2008-02-22 | Trophos Sa | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation |
FR2898272B1 (fr) | 2006-03-09 | 2008-07-04 | Trophos Sa | Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur |
FR2899108B1 (fr) | 2006-03-31 | 2012-02-03 | Trophos | Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur |
FR2914188B1 (fr) | 2007-03-28 | 2012-06-22 | Trophos | Nouvelle composition a base d'oxime de cholest-4-en-3-one |
FR2919182B1 (fr) | 2007-07-25 | 2009-11-13 | Trophos | Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants |
FR2919180B1 (fr) | 2007-07-25 | 2009-11-27 | Trophos | Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants |
NZ584849A (en) | 2007-10-30 | 2012-04-27 | Trophos | Novel composition for treating the side effects of anticancer treatments |
FR2934596B1 (fr) | 2008-07-30 | 2015-04-10 | Trophos | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation |
FR2940650B1 (fr) | 2008-12-29 | 2017-01-27 | Trophos | Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation |
-
2004
- 2004-09-07 FR FR0409436A patent/FR2874923B1/fr not_active Expired - Fee Related
-
2005
- 2005-08-19 ES ES05798253T patent/ES2390462T3/es active Active
- 2005-08-19 CA CA2576393A patent/CA2576393C/fr not_active Expired - Fee Related
- 2005-08-19 RU RU2007112950/04A patent/RU2398764C2/ru not_active IP Right Cessation
- 2005-08-19 AU AU2005281640A patent/AU2005281640B2/en not_active Ceased
- 2005-08-19 KR KR1020077007916A patent/KR101190464B1/ko active IP Right Grant
- 2005-08-19 DK DK05798253.0T patent/DK1786759T3/da active
- 2005-08-19 JP JP2007529376A patent/JP5350630B2/ja not_active Expired - Fee Related
- 2005-08-19 MX MX2007002531A patent/MX2007002531A/es active IP Right Grant
- 2005-08-19 EP EP05798253A patent/EP1786759B1/fr not_active Not-in-force
- 2005-08-19 BR BRPI0514792-1A patent/BRPI0514792A/pt not_active Application Discontinuation
- 2005-08-19 PL PL05798253T patent/PL1786759T3/pl unknown
- 2005-08-19 CN CN2005800299811A patent/CN101018762B/zh not_active Expired - Fee Related
- 2005-08-19 WO PCT/FR2005/002116 patent/WO2006027454A1/fr active Application Filing
- 2005-08-19 US US11/662,088 patent/US9045393B2/en not_active Expired - Fee Related
-
2007
- 2007-02-08 IL IL181216A patent/IL181216A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2576393A1 (fr) | 2006-03-16 |
ES2390462T3 (es) | 2012-11-13 |
RU2007112950A (ru) | 2008-10-20 |
BRPI0514792A (pt) | 2008-06-24 |
DK1786759T3 (da) | 2012-10-15 |
EP1786759A1 (fr) | 2007-05-23 |
FR2874923A1 (fr) | 2006-03-10 |
PL1786759T3 (pl) | 2012-11-30 |
KR101190464B1 (ko) | 2012-10-12 |
US9045393B2 (en) | 2015-06-02 |
AU2005281640A1 (en) | 2006-03-16 |
CA2576393C (fr) | 2013-06-11 |
JP5350630B2 (ja) | 2013-11-27 |
AU2005281640B2 (en) | 2011-02-03 |
FR2874923B1 (fr) | 2006-10-27 |
CN101018762A (zh) | 2007-08-15 |
EP1786759B1 (fr) | 2012-07-04 |
US20080275130A1 (en) | 2008-11-06 |
RU2398764C2 (ru) | 2010-09-10 |
CN101018762B (zh) | 2011-12-21 |
WO2006027454A1 (fr) | 2006-03-16 |
KR20070101218A (ko) | 2007-10-16 |
IL181216A0 (en) | 2007-07-04 |
IL181216A (en) | 2013-07-31 |
JP2008512368A (ja) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007002531A (es) | Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos. | |
WO2008108386A1 (ja) | 医薬組成物 | |
MY138941A (en) | Aryl-pyridine derivatives | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
UA94052C2 (uk) | Похідні піридазину | |
TW200833326A (en) | Chemical compounds 572 | |
MX2010008468A (es) | Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante. | |
MX2011012122A (es) | Derivados de tiofeno. | |
TN2011000446A1 (en) | 3h-imidazo [4,5-c]pyridine-6-carboxamides as anti-inflammatory agents | |
WO2007099162A3 (fr) | Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques | |
UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
MX2010006882A (es) | Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica. | |
MY151295A (en) | Pyrimidyl indoline compound | |
MX2010005824A (es) | Derivados de aminotiazol. | |
MX2011013648A (es) | Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos. | |
CA2744756A1 (en) | Monocarbams and their use as antibacterial agent | |
MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX2009003169A (es) | Derivados de sulfonamida. | |
WO2007080270A3 (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
MX2012004835A (es) | Derivados de espirolactama y usos de los mismos. | |
MX341841B (es) | Agente de prevencion o mejoramiento para la pigmentacion. | |
BRPI0514415A (pt) | composto, composição farmacêutica, e, uso de um composto | |
WO2009065090A3 (en) | Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition | |
NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
WO2008068429A3 (fr) | Composition pour la prevention et/ou le traitement des maladies associees a la surexpression du tnf et/ou de l'il-12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |